Chronic Interstitial Cystitis
11
3
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.1%
1 terminated out of 11 trials
83.3%
-3.2% vs benchmark
9%
1 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Investigation of PEMF Therapy for Female Patients With IC/BPS
Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
Pentosan Polysulfate Treatment's Effectiveness
Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome
PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome
Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder
The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study)
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions